|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
19
|
|
pubmed:dateCreated |
2007-7-2
|
|
pubmed:abstractText |
To clarify the effect of genetic polymorphisms on the response to interferon alfa (IFN-alpha) for metastatic renal cell carcinoma (MRCC), and to find a reliable molecular marker to select those patients with MRCC who would benefit from IFN-alpha immunotherapy.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
1527-7755
|
|
pubmed:author |
pubmed-author:EtoMasatoshiM,
pubmed-author:HiraoYoshihikoY,
pubmed-author:ItoNoriyukiN,
pubmed-author:JinnaiNobuyoshiN,
pubmed-author:KagawaSusumuS,
pubmed-author:KanayamaHiroomiH,
pubmed-author:KinukawaNaokoN,
pubmed-author:MasuiYoshihiroY,
pubmed-author:NaitoSeijiS,
pubmed-author:NakamuraEijiroE,
pubmed-author:NakamuraTsuyoshiT,
pubmed-author:NakazawaHayakazuH,
pubmed-author:NoseYoshiakiY,
pubmed-author:OgawaOsamuO,
pubmed-author:SekiToyokazuT,
pubmed-author:TakahashiAtsushiA,
pubmed-author:TakamatsuMasanobuM,
pubmed-author:TomaHiroshiH,
pubmed-author:TsukamotoTaijiT,
pubmed-author:UemuraHirotsuguH
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
1
|
|
pubmed:volume |
25
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2785-91
|
|
pubmed:meshHeading |
pubmed-meshheading:17602083-Carcinoma, Renal Cell,
pubmed-meshheading:17602083-Female,
pubmed-meshheading:17602083-Humans,
pubmed-meshheading:17602083-Immunotherapy,
pubmed-meshheading:17602083-Interferon-alpha,
pubmed-meshheading:17602083-Japan,
pubmed-meshheading:17602083-Kidney Neoplasms,
pubmed-meshheading:17602083-Linkage Disequilibrium,
pubmed-meshheading:17602083-Male,
pubmed-meshheading:17602083-Neoplasm Metastasis,
pubmed-meshheading:17602083-Odds Ratio,
pubmed-meshheading:17602083-Polymorphism, Genetic,
pubmed-meshheading:17602083-Polymorphism, Single Nucleotide,
pubmed-meshheading:17602083-STAT3 Transcription Factor,
pubmed-meshheading:17602083-Treatment Outcome
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
STAT3 polymorphism predicts interferon-alfa response in patients with metastatic renal cell carcinoma.
|
|
pubmed:affiliation |
Department of Urology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
